NGM BIOPHARMACEUTICALS Trademark

Trademark Overview


On Thursday, March 31, 2022, a trademark application was filed for NGM BIOPHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the NGM BIOPHARMACEUTICALS trademark a serial number of 97341658. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 1, 2024. This trademark is owned by NGM Biopharmaceuticals, Inc.. The NGM BIOPHARMACEUTICALS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the prevention and treatment of cancer, retinal, liver, metabolic, autoimmune, cardiovascular, neurological, immune, musculoskeletal, endocrine and hematological diseases and disorders

Providing medical information relating to cancer, retinal diseases and liver and metabolic diseases

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
ngm biopharmaceuticals

General Information


Serial Number97341658
Word MarkNGM BIOPHARMACEUTICALS
Filing DateThursday, March 31, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of cancer, retinal, liver, metabolic, autoimmune, cardiovascular, neurological, immune, musculoskeletal, endocrine and hematological diseases and disorders
Goods and ServicesProviding medical information relating to cancer, retinal diseases and liver and metabolic diseases
Disclaimer with Predetermined Text"BIOPHARMACEUTICALS"
Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 6, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 6, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 6, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNGM Biopharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameNGM Biopharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Tuesday, January 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 1, 2024ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 30, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 4, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 2, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 1, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 9, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 9, 2022NON-FINAL ACTION E-MAILED
Tuesday, August 9, 2022NON-FINAL ACTION WRITTEN
Thursday, August 4, 2022ASSIGNED TO EXAMINER
Wednesday, April 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 4, 2022NEW APPLICATION ENTERED